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Abstract The degradation of globotriaosylceramide (GbO- 
se3Cer) by insect-cell derived recombinant human ct-galactosi- 
dase (EC 3.2.1.22) was carried out in a detergent-free iiposomal 
system in order to mimic intralysosomal conditions. GbOse3Cer 
incorporated into unilamellar liposomes was used as the 
substrate, and naturally occurring sphingolipid activator pro- 
teins, rather than detergents, were used to stimulate the enzyme 
reaction. The degradation of GbOse3Cer was dependent on the 
presence of both ct-galactosidase and sphingolipid activator 
protein B (SAP-B or saposin B). It proceeded optimally at pH 
4.6, and was enhanced by increasing amounts of both ct- 
galactosidase (0.24-24 mU/50 lal assay) and SAP-B (0-5 pg/50 
p] assay). The enzyme reaction was not affected by SAP-A, 
SAP-C, or SAP-D. Therefore, our results indicate that only 
SAP-B is essential for the degradation of GbOse3Cer by ct- 
galactosidase. 
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I. Introduction 
Glycosphingolipids (GSL) are components of the outer leaf- 
let of the plasma membranes of vertebrate cells. After endo- 
cytosis their degradation is facilitated in lysosomes, the acidic 
compartments of the cell. According to a recent hypothesis on 
the topology of lysosomal digestion, vesicles enriched in plas- 
ma membrane components can enter into the lumen of the 
lysosomes carrying their glycosphingolipids on their outer sur- 
face facing the digestive juice of the lysosomes [1]. Here, GSL 
catabolism is catalyzed by the sequential action of exohydro- 
lases. The inherited eficiency of one of these enzymes results 
in the accumulation of its lipid substrates in the lysosomes. 
For example, the genetic defect of t~-galactosidase (EC 
3.2.1.22) encoded by a gene localized to the X-chromosomal 
region, Xq22, results in Fabry disease, which is characterized 
by intralysosomal ccumulation of GSL, predominantly GbO- 
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Se3Cer, in the cells of heart, kidney, and the vascular endothe- 
lial system [2]. 
For their lysosomal degradation by exohydrolases, everal 
GSL with short oligosaccharide headgroups need the assist- 
ance of the so-called sphingolipid activator proteins (SAPs), 
small non-enzymatic glycoproteins [1,3]. Four of the five 
known SAPs, SAP-A to D, also called saposin A-D, are de- 
rived from a common precursor [4-6]. Despite their homol- 
ogy, like the identical locations of cysteine residues and gly- 
cosylation sites, SAP-B, C and D have different functions, 
which comprise lipid binding and enzyme stimulating specific- 
ities [3,7]. On the other hand, the physiological function of 
SAP-A remains unclear because no SAP-A deficiency has 
been characterized so far [3]. 
Zschoche and co-workers [8] demonstrated that lactosylcer- 
amide (LacCer) can be hydrolyzed by two different lysosomal 
13-galactosidases, galactosylceramide- and GMl-13-galactosid- 
ase, in the presence of the activators, SAP-B or SAP-C. The 
ct-galactosidase and Ggl-13-galactosidase r both water-solu- 
ble lysosomal enzymes acting on lipid substrates, GbOse3Cer 
and LacCer. tx-Galactosidase hydrolyzes GbOseaCer to yield 
LacCer which is then degraded by the ~-galactosidases. Since 
an inherited eficiency of SAP-B results in sulfatide storage [3] 
and mild accumulation of GbOse3Cer, we attempted to clarify 
the specificities of the four SAPs, especially SAP-B and SAP- 
C, for the enzymatic hydrolysis of GbOse3Cer in vitro using a 
detergent-free liposomal system. 
2. Materials and methods 
2.1. Materials 
Restriction enzymes and T4 DNA ligase were purchased from Nip- 
pon Gene (Tokyo, Japan). Spodoptera frugiperda clonal isolated 9 
(SIX)) cells, vector plasmid pAcYM1 [9], and wild-type Autgrapha ca- 
lifornica nuclear polyhedrosis virus (AcNPV) were supplied by Dr. A. 
Takase (National Institute of Neuroscience, N.C.N.P., Tokyo, Japan). 
Egg phosphatidylcholine and dl-ctotocopherol were from Sigma (Dei- 
senhofen, Germany). Concanavalin A (Con A)-Sepharose and Mono 
Q HR 5/5 were from Pharmacia LKB Biotechnology (Uppsala, Swe- 
den). 4-Methylumbelliferyl-0~-D-galactopyranoside was from Nacalai 
Tesque (Kyoto, Japan). Lichroprep RP-18 was from Merck (Darm- 
stadt, Germany). TSKgel G3000 SWXL was from Tosoh (Tokyo, Ja- 
pan). Other reagents were of the highest grade available. 
2.2. Expression and purification of recombinant human ot-galactosidase 
Expression and purification of human t~-galactosidase w re per- 
formed according to methods described previously [10]. In brief, the 
cDNA for human ct-galactosidase (1.3 kb) was subcloned into the 
BamHI site of pAcYMI, the resultant being designated as pAcGal. 
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After co-transfection with AcNPV DNA and pAcGal into Sf9 cells, 
the recombinant virus was selected and propagated. Sf9 cells (2 × 10 7) 
were seeded in a 75 cm 2 flask, infected with the recombinant virus at a 
multiplicity of infection of 10, for 18 h, and then cultured in serum- 
free Grace's medium (10 ml) for 4 days. The expressed recombinant 
human ~-galactosidase (3 mg) was purified from the culture medium 
(200 ml) by Con A-Sepharose and Mono Q column chromatography. 
2.3. Liposomes 
GbOsezCer was tritiated at the terminal galactose [11] to a specific 
activity of 7.7 Ci/mol. Large unilamellar liposomes (80.0 +_ 25 nm) 
were prepared using modified methods of Zschoche t al. [8], and 
MacDonald et al. [12]. Liposomes with a total lipid concentration 
of 2 ~tmol/ml were prepared from egg phosphatidylcholine, 93% 
(mol/mol), dl-ct-tocopherol, 2% (mol/mol), and tritiated GbOsesCer, 
5% (mol/mol). The lipids, dissolved in ethanol, were mixed, dried at 
37°C under a stream of nitrogen, and then dispersed in an appropriate 
volume of water. After suspending the lipids by vigorous haking, the 
suspension was sonicated for 2 min in a water-cooled cup horn at 100 
W (Branson sonifier B12; Branson, Danbury, USA). The sonicated 
preparation was frozen in liquid nitrogen and thawed at 37°C four 
times. Then the preparation was extruded 19 times through an extru- 
sion device (Liposo Fast-Basic; Avestin Inc., Ottawa, Canada) using 
100 nm pore polycarbonate membranes. 
2.4. Enzyme assays 
The ct-galactosidase assay mixture comprised liposomes (10 I11, 
1 nmol of tritiated GbOse3Cer), et-galactosidase (2.4 mU), and appro- 
priate amount of SAPs, 50 mM sodium citrate buffer, pH 4.6, and 
BSA (5 Ixg), in a total volume of 50 ~tl. After incubation for 1 h at 
37°C, the reaction was terminated by the addition of 50 111 of metha- 
nol and then the reaction mixture was loaded onto a small reverse- 
phase column of RP-18 (0.25 ml). After washing the column with 100 
Ixl of chloroform/methanol/0.1 M aqueous KCI solution, 3:48:47 (v/ 
v), liberated tritiated galactose was eluted with 2 ml of water, and the 
collected radioactivity was measured with a scintillation counter. Con- 
trol radioactivity was measured by adding SAPs and enzyme only 
after termination of the incubation. SAPs, SAP-A to D, were purified 
from human tissues [7]. 
ct-Galactosidase activity was measured with 4-methylumbeUiferyl-et- 
o-galactopyranoside as the artificial substrate [10]. One unit of enzyme 
activity was defined as the amount of the enzyme that hydrolyzed 
1 Ixmol of substrate per min. 
2.5. Matrix-assisted laser desorption ionization time-of-flight mass 
spectrometry 
c~-Galactosidase was dialyzed against water and then lyophilized. 
The enzyme was dissolved in 0.1% trifluoroacetic acid to a final con- 
centration of 10 pmol/~tl (0.5 ktg/~tl). The enzyme solution (0.5 p J) was 
applied onto a stainless-steel target, 2,5-dihydroxybenzoic acid (0.5 I.tl, 
10 mg/ml), which was used as the matrix, was added and then the 
mixture was dried under an air stream. The molecular weight of a- 
galactosidase was determined by MALDI/TOF/MS (VISION 2000; 
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Fig. 1. Mass spectrum of recombinant human c~-galactosidase. (x- 
Galactosidase amounting to 0.25 ktg was subjected to MALDI/TOF/ 
MAS, as described under Section 2. Characterization of each peak 
is described in the text. 
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Fig, 2. Stimulation by SAP-B of the enzymatic hydrolysis of liposo- 
mal globotriaosylceramide. Assays were carried out in the absence 
(hatched bars) or presence of 1 ~tg of SAP-B (closed bars) using in- 
creasing ct-galactosidase activities (0.24~24 mU), as indicated. Con- 
trols (open bars) were run by adding SAP-B and 0t-galactosidase 
after termination of the incubation of liposomes. Release of radio 
labeled galactose was quantified as described under Section 2. 
Finigan MAT Instruments, Bremen, Germany), in the positive ion 
mode. 
3. Results and discussion 
o~-Galactosidase expressed in insect cells showed a homo- 
geneous activity peak corresponding to a molecular mass of 
48 kDa at pH 4.5 and at 6.0 on gel filtration (TSKgel G3000 
SWxL) analysis (data not shown), Gel-filtration analysis data 
were supported by the result of MALDI /TOF/MS analysis 
(Fig. 1). Two peaks of mlz 47881.1 and 24093.6 appeared 
which were interpreted as arising from singly and doubly 
charged recombinant ct-galactosidase, respectively. These re- 
suits indicate that the recombinant ct-galactosidase exists as a 
monomeric form in solution, in contrast to the homodimeric 
form of the native human enzyme [13,14]. The reason for the 
structural difference in the molecular assembly of both en- 
zyme preparations remains uncertain. However, it was re- 
ported that the kinetic properties, against artificial substrate, 
of recombinant ~-galactosidase closely corresponded to those 
known for c~-galactosidase purified from human spleen 
[10,14]. 
We focused our work on the hydrolysis of GbOsesCer by 
a-galactosidase, using recombinant enzyme, in the presence of 
SAPs. G~irtner and co-workers [15] already described stimula- 
tion of the degradation of micellar GbOsesCer by a-galacto- 
sidase in a detergent-free system by an activator protein. This 
protein was later shown to be identical with SAP-B [16]. How- 
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Fig. 3. Dependence of enzymatic globotriaosylceramide hydrolysis 
on increasing concentrations of the sphingolipid activator proteins, 
SAP-A to D. Reaction rates for lipid degradation by ct-galactosid- 
ase, in the detergent-free liposomal system, were determined as de- 
scribed under Section 2. Each value is the mean of duplicate deter- 
minations. SAP-A (©), SAP-B (O), SAP-C (I), and SAP-D ([3). 
ever, it has never been determined whether or not the hydro- 
lysis of liposome-integrated GbOse3Cer by ct-galactosidase i  
stimulated by SAP-B, or if the other activators, i.e. SAP-A, C 
and D, are also active. 
Liposomal GbOseaCer was hydrolyzed by recombinant hu- 
man t~-galactosidase t significant rates only after the addition 
of SAP-B (Fig. 2). In the presence of 2.4 mU of tx-galactosid- 
ase and 1 ~tg of SAP-B, about 7% of GbOseaCer present on 
the outer surface of the liposome was degraded within 1 h. 
There was a linear relationship between enzyme activity and 
reaction time until 1 h. Therefore, subsequent experiments 
were carried out with 2.4 mU of ct-galactosidase p r assay. 
As shown in Fig. 3, other activators had almost no effect. 
Highly purified preparations of SAP-A, SAP-C and SAP-D 
at concentrations up to 5 pg/assay did not enhance the hydro- 
lysis of GbOse3Cer by ~t-galactosidase significantly. These 
findings demonstrate he importance of the most active stimu- 
lator, SAP-B, for the lysosomal degradation of GbOseaCer by 
ct-galactosidase, SAP-C not being able to substitute for SAP- 
B, in contrast o the observations for the degradation of Lac- 
Cer by GMl-~-galactosidase [8].
With increasing amounts of SAP-B the breakdown of GbO- 
se3Cer by ~-galactosidase increased in hyperbolic fashion 
(Fig. 3), as would be expected from its proposed mechanism 
of action as a non-specific glycolipid binding protein lifting 
glycolipids from lipid bilayers and presenting them as sub- 
strates to their water-soluble enzymes [3]. 
Our in vitro data also support he results of loading studies 
with cultured mutant cells. Schlote and co-workers [17] re- 
ported that the catabolism of externally added GbOseaCer 
in the cultured skin fibroblasts from a patient with a genetic 
defect of SAP-B is almost as low as that in fibroblasts defec- 
tive in tx-galactosidase. 
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